Results 1 to 10 of about 47,281 (186)

Pathogenic Glomulin Gene Variant in a Patient with Idiopathic Pulmonary Arterial Hypertension: A Novel Association Case Report [PDF]

open access: yesReports
Background and Clinical Significance: Idiopathic pulmonary arterial hypertension is a rare disorder, often linked to genetic predisposition. Canonical pulmonary arterial hypertension genes such as BMPR2, KCNK3, and TBX4 are well described, but novel ...
Ilias E. Dimeas   +5 more
doaj   +2 more sources

Growing up with Idiopathic Pulmonary Arterial Hypertension: An Arduous Journey [PDF]

open access: yesPediatric Reports, 2023
Idiopathic pulmonary arterial hypertension (IPAH) is an uncommon and severe disease. We report the case of a 7-year-old boy investigated for cardiac murmur and exercise intolerance.
Tanguy Dutilleux   +4 more
doaj   +2 more sources

Scleroderma pulmonary arterial hypertension: the same as idiopathic pulmonary arterial hypertension? [PDF]

open access: yesCurr Opin Pulm Med, 2023
Purpose of review Pulmonary arterial hypertension (PAH) is a common complication of systemic sclerosis (SSc), which confers significant morbidity and mortality. The current therapies and treatment strategies for SSc-associated PAH (SSc-PAH) are informed by those used to treat patients with idiopathic PAH (IPAH).
Khan SL, Mathai SC.
europepmc   +3 more sources

Cardiac sympathetic dysfunction in pulmonary arterial hypertension: lesson from left-sided heart failure [PDF]

open access: yesPulmonary Circulation, 2019
Sympathetic nervous system hyperactivity has a well-recognized role in the pathophysiology of heart failure with reduced left ventricular ejection fraction.
Valentina Mercurio   +10 more
doaj   +2 more sources

Idiopathic pulmonary arterial hypertension [PDF]

open access: yesDisease Models & Mechanisms, 2010
Despite improved understanding of the pathobiology of pulmonary arterial hypertension (PAH), it remains a severe and progressive disease, usually culminating in right heart failure, significant morbidity and early mortality. Over the last decade, some major advances have led to substantial improvements in the management of PAH.
Amy L, Firth   +2 more
  +6 more sources

Reverse Potts for the Treatment of Severe Idiopathic Pulmonary Hypertension in Children [PDF]

open access: yesBrazilian Journal of Cardiovascular Surgery, 2023
Idiopathic pulmonary arterial hypertension is a rare and progressive disease with poor prognosis. Many patients progressively worsen even when using combinations of specific drugs for its treatment.
Marcelo Frederigue de Castro   +5 more
doaj   +1 more source

Pulmonary hypertension associated with neurofibromatosis type 2

open access: yesPulmonary Circulation, 2021
Although precapillary pulmonary hypertension is a rare but severe complication of patients with neurofibromatosis type 1 (NF1), its association with NF2 remains unknown.
Hirohisa Taniguchi   +9 more
doaj   +1 more source

Endothelial platelet-derived growth factor-mediated activation of smooth muscle platelet-derived growth factor receptors in pulmonary arterial hypertension

open access: yesPulmonary Circulation, 2020
Platelet-derived growth factor is one of the major growth factors found in human and mammalian serum and tissues. Abnormal activation of platelet-derived growth factor signaling pathway through platelet-derived growth factor receptors may contribute to ...
Kang Wu   +21 more
doaj   +1 more source

Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood

open access: yesNature Communications, 2021
Idiopathic pulmonary arterial hypertension is a rare and fatal disease with a heterogeneous treatment response. Here the authors show that unsupervised machine learning of whole blood transcriptomes from 359 patients with idiopathic pulmonary arterial ...
Sokratis Kariotis   +34 more
doaj   +1 more source

Home - About - Disclaimer - Privacy